The ACLT group exhibited reduced expression of PPAR‐γ, GLUT1, aggrecan, and collagen II, alongside increased collagen I expression, indicating chondrocyte metabolic disorders and phenotypic loss (Figure 7D–H). This evidence concerns the gene ACAN and Other metabolic disease.